Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has disclosed two upcoming investor/analyst meetings scheduled for late May 2026. The first is a group or one-on-one meeting at the Ambit India Access Titans of Tomorrow Conference on May 25 in Mumbai. The second is a one-on-one meeting with Abakkus Asset Managers on May 27, also in Mumbai. The company notes that schedules may change due to exigencies. This is a routine regulatory disclosure under SEBI LODR Regulation 30, requiring companies to inform exchanges about investor interactions.
No material impact on stock price expected. This is a standard disclosure informing investors of scheduled institutional meetings, which is routine for listed companies. No new business or financial information was shared.